Lerna Biopharma
Company

Lerna Biopharma

Biotechnology Research Singapore, Central Singapore, Sg 4 employees
Employees
4
Contacts
2
Emails
2

Lerna Biopharma Overview

Headquarters
Singapore, Central Singapore, Sg
Industry
Biotechnology Research
Employees
4
Founded
2020
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Lerna Biopharma

Founded in 2020, Lerna Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver diseases and ophthalmic disorders, with operations in Singapore, China and USA. Using proprietary platforms backed by novel biology and chemistry insights, Lerna aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases. In December 2021, Lerna successfully closed an over-subscribed US$19.2 million pre-Series A funding round led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other renowned investors.

Lerna Biopharma Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage

Lerna Biopharma Org Chart

Sample employees and titles
Name Title Contact
Adelyn Tan Research Officer at A*star - Agency
Email
Torsten Wuestefeld Associate Professor of Molecular
Email

Compare Similar Companies to Lerna Biopharma